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Abstract 
Background: Sexual dysfunction in women is very common and it 
affects physical and mental health. Several studies have been 
conducted in Iran in order to investigate the prevalence of female 
sexual dysfunction. However, there is a remarkable diversity among the 
results. This meta-analysis was conducted to estimate the overall 
prevalence of female sexual dysfunction in Iran. 
Methods: International and national electronic databases were 
searched up to June 2016, which included MEDLINE, Science Citation 
Index Expanded, Scopus, ISI, Google Scholar, IranDoc, SID, MagIran, 
and IranMedex, as well as conference databases. Furthermore, 
reference lists of articles were screened and the studies’ authors were 
contacted for additional references. Cross-sectional studies addressing 
the prevalence of female sexual dysfunction were included in this meta- 
analysis. 
Results: We assessed eight separate studies involving 5,778 
participants overall, of which 2,335 had sexual dysfunction. Overall 
prevalence rate of female sexual dysfunction was 0.48 (0.38, 0.59).  
Conclusions: Various prevalences of sexual dysfunction have been 
reported in different studies. Furthermore, despite many studies 
conducted addressing the prevalence of female sexual dysfunction, 
there is however a remarkable diversity between the results. Thus one 
can hardly give a precise estimation of the prevalence rate of female 
sexual dysfunction in Iran at the moment. 
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Introduction 
The World Health Organization (WHO) defines sexual 
health as physical, emotional, mental and social well-being, not 
just the absence of weakness, disease and disability in relation 
to sexuality. Sexual health requires a positive and respectful 
approach to sexuality and sexual relationships with sexual 
experience being safe and enjoyable without any coercion, 
discrimination, and violence. To obtain and maintain sexual 
health, sexual rights of all persons must be respected, protected 
and fulfilled.1 
According to Diagnostic and Statistical Manual of Mental 
Disorders, fifth edition (DSM5), sexual dysfunction in women 
includes orgasmic disorder, interest/arousal disorder, 
genitopelvic pain, penetration disorders, and substance and 
drug-use disorders. Sexual dysfunction is a heterogeneous 
group of disorders that is clinically significant disorder in the 
ability for sexual response and having an enjoyable sexuality.2 
Female sexual dysfunction (FSD) is a multidimensional 
medical subject with biological, psychological, and 
interpersonal determinants. It is very common among women 
in westernized countries.3 
Sexual dysfunction has major effects on quality of life in 
women. Sexual dysfunction has damaging impact on self-
esteem, sense of wholeness and interpersonal relationships of 
women. It is often emotionally distressing. If female sexuality 
is disturbed, the consequences are that it might lead to familial 
conflict and divorce, and reproduction is also affected.4 
An analysis of data in the US from the National Health and 
Social Life Survey found that sexual dysfunction is more 
common in women (43 %) than in men (31 %), and the 
prevalence varied among women of different racial groups.5 
In Middle Eastern countries, family is the very basic unit of 
the society. Sexual dysfunction is an important issue that 
affects the family’s well-being. Many women with important 
sexual dysfunction in this part of the world do not consult their 
family physicians about their problems that are possibly related 
to cultural factors.6 
Prevalence of sexual dysfunction varies in different 
communities and is caused by medical factors, psychological, 
socio-economic, cultural and racial factors. In recent years, the 
prevention, diagnosis and treatment of sexual dysfunction has 
been the source of a lot of attention. For the diagnosis and 
treatment of sexual dysfunction, we will first need to determine 
the exact prevalence of these disorders. Several studies have 
been conducted in Iran in order to investigate prevalence of 
female sexual dysfunction. However, there is a remarkable 
diversity among the results.7-14 Thus this meta-analysis was 
conducted in order to estimate an overall summary measure of 
prevalence rate of sexual dysfunction among women in Iran.  
Materials and Methods  
We included all cross-sectional studies investigating the 
prevalence of female sexual dysfunction, irrespective of 
publication status or language. Cohort and case-control studies 
were excluded. Women with chronic or severe medical 
illnesses or psychiatric illnesses, drug abuse, infertility, 
menopause, and those who were pregnant or were within two 
months postpartum, were excluded from the study. 
We used and combined the following keywords: 
“dysfunction or disorder; and female or women; sexual; and 
Iran”. We searched both international and national electronic 
databases as follows: MEDLINE (January 1990 to June 2016); 
Science Citation Index Expanded (January 1990 to June 2016); 
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Scopus (November 2000 to August 2016); SID (January 2000 
to August 2016); Magiran (January 2000 to August 2016); and 
Iran Medex (January 2000 to August 2016). We also scanned 
the reference lists of all included studies for additional 
references. We contacted the authors of included studies for 
additional eligible studies.  
Title and abstract of the retrieved studies were screened to 
decide on which studies met the inclusion criteria of this meta-
analysis. Then, the full texts of eligible studies were reviewed 
and necessary data were extracted and entered into an 
electronic datasheet. The authors were not blinded to the names 
of the studies’ authors, journals, and results. Any 
disagreements were resolved through discussion among the 
authors until consensus was reached. Nine items of STROBE 
checklist15 were used to assess the risk of bias in the included 
studies. The studies with at most one unclear or inadequate 
quality component were considered studies with low risk of 
bias, otherwise they were considered as high risk. We explored 
statistical heterogeneity using the chi-squared (Chi2) test at 5% 
significance level (P < 0.05). We quantified inconsistency 
across study results using eight statistics.16 We also estimated 
the between-study variance using the tau-squared (Tau2) 
statistic.17 We used funnel plot to investigate publication bias.17 
In addition, we used Begg18 and Egger19 statistical tests to 
assess publication bias quantitatively. Review Manager 520 
software was employed for data analysis. Meta-analysis was 
performed to obtain summary measure of “prevalence rate” of 
female sexual dysfunction. Data were analyzed and the results 
were reported using a random effect model21 with 95% 
confidence interval (CI). 
Ethical issues (Including plagiarism, informed consent, 
misconduct, data fabrication and/or falsification, double 
publication and/or submission, redundancy, etc.) have been 
completely observed by the authors. 
Results 
We retrieved 228 records through database screening of 
MEDLINE, Science Citation Index Expanded, Scopus, ISI, 
Google Scholar, Iran Doc, SID, Magiran, and Iran Medex. Of 
62 references considered potentially eligible for this meta-
analysis, 25 studies were excluded after screening the titles and 
abstracts and 37 studies were excluded after reviewing full 
texts. Finally, eight studies were included for meta-analysis 
(Figure 1). 
Of eight included studies, three studies were published in 
English7,8,12 and five studies in Persian. (Table 1) 9,10,11,13,14 
The lowest prevalence rate of female sexual dysfunction 
(31%) was reported by Mazinani et al.9 in Tehran City and the 
highest prevalence rate (64.6%) was related to the study which 
was conducted by Bahrami et al. in Dezful City.13 
We included in the meta-analysis of eight studies with 
5,778 participants overall, of which 2,335 had female sexual 
dysfunction. As shown in Figure. 2, the overall prevalence rate 
of female sexual dysfunction was 0.48 (95% CI; 0.38, 0.59). 
According to Table heterogeneity, the article heterogeneity is 
minimal and equal to 0.02 (Figure. 2). 
Figure 1. Flow diagram of the progress through the phases of meta-analysis  
128 records after 
duplicates removed 
91 records excluded as not eligible 
after screening title and abstract 
37 full-text articles 
assessed for eligibility 
29 not performed in 
general population 
8 studies include in quantitative 
synthesis (meta-analysis) 
228 records identified through database screening (MEDLINE, 
Science Citation Index Expanded, Scopus, ISI, Google Scholar, Iran 
Doc, SID, Magiran, and Iran Medex) 
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Figure 2. Forest plot of prevalence rate of female sexual dysfunction 
Figure 3. Funnel plot for assessing publication bias in the included studies (with 
pseudo 95% confidence limits) 
We assessed reporting bias using the funnel plot. The 
studies were distributed symmetrically around the vertical line 
indicating that no publication bias had occurred (Figure. 3). 
The statistical test for publication bias including Begg and 
Egger tests was not significant, confirming absence of 
publication bias. 
There were four low-risk studies7,10,13,8 and four high-risk 
studies9,11,12,14 among the included studies (Figure. 4). 
 
Figure 4. Risk of bias indicating the review authors’ judgments about each risk-
of-bias item for each included study 
Discussion 
Female sexual dysfunction in women has major effects on 
quality of life and interpersonal relationships. For many 
women, it is physically disturbing, emotionally worrying and 
socially impairing.8 
Eight studies were included in assessment of prevalence of 
sexual disorders among women. Although there were other 
cl
ea
rly
 d
ef
in
e 
fe
m
al
e 
se
xu
al
dy
sf
un
ct
io
n
bahramy +
bolorian 2007 +
hosseini2006 +
jafarpor2012 –
mazinani2012 +
mohammad alizade2014 +
safarinejat2007 +
shokrolahi1999 +
gi
ve
 th
e 
el
ig
ib
ili
ty
 c
rit
er
ia
+
+
+
+
+
+
+
+
gi
ve
 p
re
ci
si
on
 o
f t
he
 s
tim
at
e
+
+
+
+
+
+
+
+
in
di
ca
te
 th
e 
st
ud
y 
de
si
gn
+
+
+
+
+
–
+
+
ex
pl
ai
n 
sa
m
pl
e 
si
ze
 c
al
cu
la
tio
n
–
–
–
–
–
–
–
–
de
sc
rib
e 
th
e 
lo
ca
tio
n
+
+
+
+
+
+
+
+
de
sc
rib
e 
th
e 
da
te
+
+
+
+
–
+
+
+
so
ur
ce
s 
of
 m
ea
su
re
m
en
t d
at
a
+
–
+
+
+
+
+
+
de
m
og
er
ap
hi
c 
ch
ar
ac
te
ris
tic
s 
of
 th
e 
sa
m
pl
e
+
–
+
+
+
+
+
+
Table 1. Characteristics of the studies under investigation 
Total prevalence Instrument Location, Time frame of the study Sample size Author 
31 SFQ Dezful, 2008 250 Bahramy 
63.2 Researcher-designed Sabzevar, 2003 366 Bolorian 
45.2 FSFI Sari, 2006 899 Hosseini 
46.2 FSFI Ilam, 2010-2011 400 Jafarpor 
31 SFQ Tehran, 2012 405 Mazinani 
66 FSFI Tabriz, 2012 532 Mohammad Alizade 
31.5 FSFI Tehran, 2006 2626 Safarinejat 
38 BISF-W Tehran, 1999 300 Shokrolahi 
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studies available, they were not included either as a result of 
lacking inclusion criteria or due to the impossibility of getting 
access to the full texts. 
The results of this meta-analysis revealed that the 
prevalence of rate of female sexual dysfunction is very high, 
with nearly 48% of women being affected by sexual 
dysfunction. This should be considered a serious caution that 
sexual dysfunction is a threat to mental health, and it should be 
the focus of special attention, particularly by psychologists. 
However, sexual dysfunction is not unique to Iran. Sexual 
dysfunction is comparable to the international statistics 
available. For instance, Nicolosky et al. reported a prevalence 
of 30% in their study on 3,350 Asian women, while Laumann 
et al. found a prevalence of 43% in their study conducted on a 
sample of 1,749 American women.4,22 Sexual dysfunction is 
affected by medical factors, psychological, socio-economic, 
cultural, and racial factors. 
To discuss the underlying reasons for the existing 
differences in the statistics of the studies, the following points 
can be presented: 1. the main reasons for the differences 
between Iranian statistics and statistics of other studies might 
be in the use of different questionnaires, for instance, Mazinani 
has used FSFI, while Shokrollahi collected BISF-W; 2. existing 
difference in the sampling methods, number of samples and 
inclusion criteria used, for instance Hosseini included 899 
women referred to the health center of Sari with multistage 
sampling, Jafarpor included 400 women from four primary 
health clinics of Illam with random sampling, Safarinejat 
included 2,626 women with two-stage cluster random sampling 
in the primary sampling unit, Mazinani included 405 married 
women with multi-stage sampling, Mohammad Alizadeh 
included 532 women with two-stage cluster sampling, Bahramy 
included 250 women with convenience sampling, Bolorian 
included 366 women with convenience sampling, and 
Shokrollahi included 300 women with convenience sampling; 
3. the difference in data collected included face-to-face 
interviews and completing a self-administer questionnaire. The 
possibility of biases in face-to-face interviews was due to lack 
of privacy. Meta- analysis can be a beneficial and efficient 
method to utilize the findings of the studies. 
The results of this review showed prevalence rates of 
female sexual dysfunction were reported in a wide range in 
different studies. Planning is essential to identify and resolve 
the impact of sexual dysfunction on inter-personal functioning 
and overall quality of life in both men and women. A limitation 
of this study was that it collected cross-sectional studies only in 
women of childbearing age. It is recommended that such 
studies be done in all patients, including pregnant women, 
breastfeeding mothers, and elderly women. However, 
conducting a national survey may be helpful. 
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